Opinion: The European Union’s new rule signals a new era for agriculture

The European Parliament’s decision to adopt the new rules for the regulation of gene-edited crops marks a notable turning point that U.S. policymakers, farmers and innovators cannot afford to ignore.

Europe has historically taken a more restrictive stance on agricultural biotechnology than many of its global peers. That posture has not only shaped its local farm economy, but also where investments are made, how trade flows and what new tools reach the field.

With this new regulation, things are about to change.

By creating a clearer pathway for most gene-edited crops – particularly those that could occur through conventional breeding – the European Union is shifting toward a more science-based, risk-proportionate approach. It is not a wholesale departure from precaution, but it is a meaningful step toward aligning regulation with the underlying biology and aims to empower the next wave of innovation in biotechnology.

This moment carries both opportunity and urgency. The U.S. has long been a leader in agricultural innovation, supported by an enabling regulatory framework and heavy investments in R&D that have benefited the local economy. Maintaining this leadership will require continued investment, policy clarity and the ability to bring innovations to market efficiently.

In a global industry like agriculture, this policy shift impacts stakeholders across the value chain.

Worldwide, farmers are managing increasingly complex challenges with volatile weather, shifting pest pressures, tight margins, trade wars and growing expectations around sustainability. Meeting those demands in a timely manner requires the development of and the access to new tools.

Gene editing brings forward one such tool. Unlike traditional genetic modification, it enables precise changes within a plant’s existing DNA. This accelerates what nature and conventional breeding can do, but with far greater speed and accuracy. Gene editing unlocks the potential for crops that use fewer inputs, tolerate stress more effectively, and deliver stronger yields under real-world conditions.

At the same time, the industry’s ability to take advantage of these innovative tools requires fit-for-purpose regulatory frameworks across borders to support trade and market access.

Governments around the world are reassessing how best to regulate emerging breeding technologies, with many putting a stronger focus on outcomes over methodology. Some have already adopted frameworks similar to what the EU is now advancing, and we have seen more and more countries clearly distinguish gene editing from more traditional biotechnology by exempting it from GMO regulations. As this alignment grows, the barriers to scaling agricultural innovations shrink.

This also brings forward incredible opportunities for companies of all shapes and sizes to thrive. While it will take about two years for the new regulations in the EU to be fully implemented, the work to make use of these new breeding technologies is already in motion. Several start-ups have emerged in the region over the past couple of years, and our team at Inari has established partnerships with customers in Europe who wanted to get a jump-start.

But we must remember the lessons we learned during our journey with biotechnology over the past decades. Science alone is not enough. Continuing to build trust is essential to realizing the full promise of gene editing. This means engaging openly with farmers, consumers and policymakers. It also means demonstrating tangible benefits, maintaining high standards for safety, and ensuring that innovation is reasonably accessible across the agricultural system.

Europe’s decision is not a final destination. It’s an inflection point. The details of implementation will matter while debates around intellectual property, labeling and coexistence continue. Those are important conversations that should be informed by scientific evidence, stakeholder perspectives and practical applications.

What is clear, however, is that the global direction has clearly shifted. The move by the EU opens its doors to new breeding techniques and reinforces a broader trend toward policies that enable innovation while safeguarding public confidence. For U.S. agriculture, the challenge and the opportunity is to stay at the forefront of that movement.

I look forward to seeing this momentum continue, with other governments using the EU’s framework as an example as they work to enable the next revolution in agriculture. I believe gene editing is going to unlock new possibilities to help farmers flourish while making the best use of our natural resources. This is how we will best position ourselves to provide food security to global communities for generations to come.

Lisa Safarian is the CEO of Inari.